Cancer is our SPECIALTY. Healing is our PASSION.
Integrated on-site cancer care options help streamline patient testing and facilitate the patient care cycle. Our efficient all-in-house services save patients time and resources while enabling us to easily keep you updated on your patient’s progress.
Each of our cancer centers is easily accessible and conveniently located close to home. Our relaxed, family-oriented environment and caring staff help put patients and their families at ease. We take pride in our patient satisfaction and quality of care. Our Staff includes physicians and support staff fluent in Spanish as well as several other languages.
We have simplified the patient referral process to save you time and to ensure we see your patient as quickly as possible. Our referral process is completed in two easy ways:
By Telephone - A well-trained Medical Representative will be there to meet your needs. You can find the appropriate number on our locations list.
- By Fax - Complete our referral form and fax it to the office of your choice. Within 24 hours, we will contact your staff to advise you of the date and time of your patient’s scheduled appointment. View locations list.
If you need more information about our clinical trials program or if you have a patient who might meet eligibility requirements for a specific research study, please see our Clinical Research & Trials section.
Cancer in the News
- Novel regulator of the activity of a protein inactive in over 50% of human tumors
- Intervention strategy in in low-income families helps parents nurture children and reduce inflammation
- Genes identified that contribute to radiation resistance
- Bioreactor-on-a-chip could help meet growing need for blood transfusions worldwide
- 'Pathogenic connection' between cancer and autoimmune disorders
- In diseases like cancers and psoriasis, degradation is key to the activity of the miR-21 oncomiR
- New, powerful single-cell technique developed to study environmental effects on DNA
- Enzyme lost in 100 percent of kidney tumors analyzed
- Gene known as MED12 is altered in nearly 60 percent of fibroadenomas
- Possible target identified for immunotherapy in early-stage breast cancer
- Targeted virus could boost chemo's effects for arm and leg cancer
- Study examines presence of uterine cancers among women at the time of hysterectomy using morcellation
- Hidden information behind imaging tests for cancer may unlock new approaches to radiation therapy
- Innovative data collection system for cancer patients developed to improve care and outcomes